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however, persistence of interseptovalvular space with the embryonic
left venous valve remnant as the incomplete partition may explain the
morphogenesis of the midline chamber. Because of marked asymme-
try in the timing and sequence of events for pulmonary venous
development, a process of differential pulmonary venous segregation,
which supports the primary theory,4 may explain right pulmonary
vein malincorporation into the midline chamber.
Although appreciation of the developmental basis would not
have altered the surgical approach, recognition of precise anatomic
disposition of this unusual anomaly is essential for effective plan-
ning of the appropriate corrective surgical strategy. Awareness of
the exact nature of the pulmonary venous drainage is pivotal to the
prevention of pulmonary venous obstruction and its ensuing ad-
verse hemodynamic effects.
References
1. Uemura H, Ho SY, Devine WA, Kilpatrick LL, Anderson RH. Atrial
appendages and venoatrial connections in hearts from patients with
visceral heterotaxy. Ann Thorac Surg. 1995;60:561-9.
2. Michaud P, Dallaz C, Age´ C. A propos d’un nouveau cas de coeur triatrial
de l’adulte ope´re´ avec succe´s. Arch Mal Coeur. 1970;63:291-300.
3. Thilenius OG, Bharati S, Lev M. Subdivided left atrium: an expanded
concept of cor triatriatum sinistrum. Am J Cardiol. 1976;37:743-52.
4. Webb S, Kanani M, Anderson RH, Richardson MK, Brown NA. De-
velopment of the human pulmonary vein and its incorporation into the
morphologically left atrium. Cardiol Young. 2001;11:632-42.
5. Blom NA, Gittenberger-de Groot A, Jongeneel TH, DeRuiter MC,
Poelmann RE, Ottenkamp J. Normal development of the pulmonary
veins in human embryos and formulation of a morphogenetic concept
for sinus venosus defects. Am J Cardiol. 2001;87:305-9.
Completion lobectomy after bilateral lung
volume reduction for emphysema: Salvage
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Bilateral lung volume reduction (LVR) can significantlyimprove the functional capacity of selected patientswith severe emphysema and an upper-lobe predomi-nance of disease.1,2 However, because of its palliative
nature, postoperative improvements usually peak within the first 6
months and slowly decline subsequently, eventually returning back
to the baseline status in most patients. Little is known, however, as
to whether redo LVR3 can be reasonably proposed in selected
patients after bilateral LVR.
Herein we describe 4 patients with upper-lobe prevailing em-
physema who underwent completion lobectomy (CL) as a redo
LVR after a previous bilateral operation. The patients, all men,
were operated on between September 2001 and October 2002. All
patients gave their written, informed consent. The mean interval
between bilateral LVR and CL was 59 months. After the bilateral
operation, marked improvements occurred in pulmonary function
measures: 360 mL in forced expiratory volume in 1 second
(FEV1), 1170 mL in residual volume, 125 m in the 6-minute
walking test, and 5.25 mm Hg in arterial oxygen tension. After-
ward, the FEV1 annual decline averaged 0.23  0.09 L at 24
months and 0.08 L at 36 months.
CL was performed when FEV1 returned to baseline values and
high-resolution computed tomography showed severe emphyse-
matous lung destruction that was prevailing in 1 upper lobe (Figure
1,1 and 2). Before CL, all patients were receiving maximized
medical therapy and underwent a 4-week respiratory rehabilitation
program.
CL (3 right upper lobectomies and 1 left upper lobectomy) was
performed by video-assisted minithoracotomy (2 patients) or lat-
eral thoracotomy (2 patients). In 2 instances, isolation of the hilar
structures was accomplished in a standard manner. In another 2
patients, the fissure was not dissected free, and the upper lobe
tissue was excised through nonbuttressed staple resection (Figure
2). All patients were extubated in the operating room, but 1
required early reintubation and eventually died of respiratory fail-
ure. In the remaining 3 patients, there were no major complica-
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Figure 1. High-resolution computed
tomography of a patient who under-
went CL after previous bilateral
LVR. Before surgery (1 and 2), a
completely destroyed and hyperin-
flated right upper lobe was shown;
after surgery (3 and 4), a meaningful
reduction in the overall lung volume
occurred in both lungs after right
upper CL.
TABLE 1. Demographics before and 6 mo after completion lobectomy measures
Variable Patient 1 Patient 2 Patient 3 Patient 4
Age (y) 63 66 65 71
Interval between bilateral
LVR and CL (mo)
49 61 64 62
Surgical procedure Right upper CL Left upper CL Right upper CL Right upper CL
Morbidity — Prolonged air leak,
respiratory failure
Prolonged air leak —
FEV1 (L)
Before CL 0.72 0.52 0.71 0.60
After CL 0.80 — 0.93 0.84
FVC (L)
Before CL 1.91 1.75 1.81 1.63
After CL 2.12 — 1.94 1.92
RV (L)
Before CL 4.9 5.7 5.8 5.3
After CL 4.2 — 5.2 4.6
SMWT (m)
Before CL 230 180 340 300
After CL 290 — 420 370
PaO2 (mm Hg)
Before CL 67 57 63 60
After CL 69 — 67 63
DLCO (%)
Before CL 38 18 40 36
After CL 41 — 38 36
Systolic PAP (mm Hg)
Before CL 31 42 22 28
After CL 30 — 27 29
Follow-up (mo) 19 — 9 23
Status Alive Dead Alive Alive
CL, Completion lobectomy; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; RV, residual volume; SMWT, 6-min walking test; PaO2, arterial
oxygen tension; DLCO, diffusion capacity for carbon monoxide; PAP, pulmonary artery pressure; LVR, lung volume reduction.
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tions. The mean in-hospital stay was 11 days. Meaningful im-
provements occurred in all survivors 6 months after CL, as detailed
in Table 1. Right heart catheterization showed no significant
changes in pulmonary artery pressure.
So far, no patient is dead or mechanically ventilated. Severe
osteoporosis developed in 1 patient because of prolonged steroid
therapy.
This is the first report dealing with redo LVR in patients with
cigarette smoking–related severe emphysema and upper lobe pre-
dominance. Stammberger and coworkers3 have already reported
on a patient with 1-antytripsin deficiency emphysema, who also
benefited from redo LVR.
CL resulted in meaningful functional improvements in 3 of 4
patients, and in no instance did pulmonary hypertension, which
can occur after bilateral LVR,4 develop. Nonetheless, 1 patient
died of respiratory failure after surgery. We believe that he prob-
ably had too-advanced disease in the remaining lung tissue, with a
scarcely heterogeneous pattern of emphysema.
Anatomic resection is considered contraindicated in patients
with emphysema because of the risk of removal of functioning
lung tissue. However, lobectomy has been recently reported5 as a
successful LVR procedure in patients with severely emphysema-
tous lung lobes. Despite the very limited cohort, our results suggest
that in stringently selected patients with a completely destroyed
and functionally useless residual upper lobe, CL can be followed
by meaningful improvements in respiratory function measures and
exercise capacity.
We advise that CL be strictly performed in patients who have
already benefited meaningfully from the first reduction, because it
is highly unlikely that a patient who did not benefit from LVR
initially will improve after CL. We believe that one reliable way of
monitoring the patient’s condition is observing the FEV1 decay. In
fact, FEV1 is a reliable measure of the severity of chronic obstruc-
tive pulmonary disease and is correlated with the clinical benefit of
LVR. Our data suggest that FEV1 decay is maximal between 12
and 24 months and becomes less steep subsequently. However, the
unavoidable and sometimes accelerated functional decline ob-
served after LVR emphasizes that more efforts must be devoted to
improve the current surgical techniques.
We conclude that in carefully selected patients, CL can prolong
the benefits of LVR, a surgical option that continues to stimulate
active investigation and to raise concerns and skepticism but that
can undoubtedly offer some hope to properly selected patients with
severe emphysema.
This study was performed within the Research Fellowship
Program Tecnologie e Terapie Avanzate in Chirurgia awarded by
the Tor Vergata University.
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Figure 2. Completion lobectomy specimen (right upper lobe) after
bilateral LVR.
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